Invoy is a health startup that aims to empower individuals to manage their health through science, devices, and supportive analysts. With over a decade of research focused on breath analysis, the company offers personalized weight management programs utilizing an intuitive breath device, pioneering science, and a team of caring analysts to bridge the gap between data and actionable insights.
Founded in 2008, Invoy operates in the Health Care, Health and Wellness, and Medical Devices industries, demonstrating a strong commitment to affordable and accessible health solutions. The company's track record includes extensive research on respiratory chemistry and physiological conditions across diverse populations.
The most recent investment of $5.12M in a Series A round occurred on 15 September 2020, with participation from Touchdown Ventures and Khosla Ventures. This noteworthy investment indicates a strong interest from established ventures, highlighting the potential for Invoy's innovative approach to health management.